Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Azaz Ahmed

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3000-7951; OpenAlex author ID A5059948661. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers

Papers 10

  1. ChatGPT vs. surgeons on pancreatic cancer queries: accuracy & empathy evaluated by patients and experts. Co-author DOI 10.1016/j.hpb.2024.11.012↗
  2. De novo induction of tertiary lymphoid structures: an immunotherapeutic strategy in pancreatic cancer. Co-author DOI 10.1038/s41392-025-02260-5↗
  3. [Sex differences in pancreatic cancer]. First author DOI 10.1007/s00104-024-02150-6↗
  4. Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients w… Co-author DOI 10.1111/cts.13661↗
  5. Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients. Co-author DOI 10.3390/cancers15061815↗
  6. Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2022.2027148↗
  7. Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2022.947407↗
  8. Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic… Co-author DOI 10.1080/2162402x.2021.1962135↗
  9. Langerhans islets induce anti-tumor immunity at the expense of glycemic control and predict chemotherapy response in pancreatic cancer Co-author DOI 10.1101/2021.03.13.435100↗
  10. Top ten research priorities for pancreatic cancer therapy. Co-author DOI 10.1016/s1470-2045(20)30179-0↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rosa Klotz · 8 shared papers, 2020–2025 · strength 1.37
  2. Christoph Springfeld · 7 shared papers, 2021–2025 · strength 1.31
  3. Niels Halama · 6 shared papers, 2021–2025 · strength 1.17
  4. Thilo Hackert · 6 shared papers, 2020–2023 · strength 0.86
  5. Nathalia A. Giese · 5 shared papers, 2021–2023 · strength 0.74
  6. Martin Loos · 2 shared papers, 2024–2025 · strength 0.51
  7. Christoph W. Michalski · 2 shared papers, 2024–2025 · strength 0.51
  8. Magdalena Holze · 1 shared paper, 2024 · strength 0.28
  9. Thomas Moritz Pausch · 1 shared paper, 2025 · strength 0.23
  10. Susanne Roth · 1 shared paper, 2025 · strength 0.23
  11. Jörg Kaiser · 1 shared paper, 2025 · strength 0.23
  12. Christoph Kahlert · 1 shared paper, 2025 · strength 0.23
  13. Karen Steindorf · 1 shared paper, 2023 · strength 0.14
  14. Nicolas Hohmann · 1 shared paper, 2023 · strength 0.14
  15. Martin Ronald Sprick · 1 shared paper, 2023 · strength 0.14
  16. Andreas Trumpp · 1 shared paper, 2023 · strength 0.14
  17. Jacek Hajda · 1 shared paper, 2023 · strength 0.14
  18. Thomas Theodor Werner Seufferlein · 1 shared paper, 2023 · strength 0.14
  19. Jens Thomas Siveke · 1 shared paper, 2023 · strength 0.14
  20. Albrecht Stenzinger · 1 shared paper, 2023 · strength 0.14
  21. Markus K. Diener · 1 shared paper, 2020 · strength 0.12
  22. André L. Mihaljević · 1 shared paper, 2020 · strength 0.12
  23. Thomas Schmidt · 1 shared paper, 2021 · strength 0.10
  24. Meggy Suarez‐Carmona · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.